glp 1/gip medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GIP Medications for Seniors -

Trulicity can cause weight loss, although it is not a weight loss drug

Cons Mixed reviews regarding their customer service

Nassif ME, et al

Since branded semaglutide and tirzepatide are now fully available, prescribers are expected to document that the compounded version serves a specific individualized medical need that the branded version cannot

17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD